New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - sildenafil citrate 35.12mg equivalent to 25 mg sildenafil;  ;   - tablet - 25 mg - active: sildenafil citrate 35.12mg equivalent to 25 mg sildenafil     excipient: croscarmellose sodium hypromellose indigo carmine lactose monohydrate macrogol 6000 magnesium stearate microcrystalline cellulose povidone titanium dioxide - sildenafil is indicated for the treatment of erectile dysfunction in adult males.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - sildenafil citrate 70.24mg equivalent to 50 mg sildenafil;  ;   - tablet - 50 mg - active: sildenafil citrate 70.24mg equivalent to 50 mg sildenafil     excipient: croscarmellose sodium hypromellose indigo carmine lactose monohydrate macrogol 6000 magnesium stearate microcrystalline cellulose povidone titanium dioxide - sildenafil is indicated for the treatment of erectile dysfunction in adult males.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - azathioprine 100mg;   - film coated tablet - 100 mg - active: azathioprine 100mg   excipient: croscarmellose sodium maize starch mannitol microcrystalline cellulose opadry clear oy-7240 povidone sodium stearyl fumarate - azamun is used as an immunosuppressant anti-metabolite either alone, or more commonly in combination with other agents (usually corticosteroids) and procedures that influence the immune response. the therapeutic effect of azamun may be evident only after weeks or months and can include a steroid-sparing effect, thereby reducing the toxicity associated with high dosage and prolonged use of corticosteroids. azamun, in combination with corticosteroids and/or other immune-suppressive agents and procedures is indicated to enhance survival of organ transplants, such as renal, cardiac and hepatic transplants; and to reduce corticosteroid requirements of renal transplant recipients.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - azathioprine 25mg;   - film coated tablet - 25 mg - active: azathioprine 25mg   excipient: croscarmellose sodium maize starch mannitol microcrystalline cellulose opadry clear oy-7240 povidone sodium stearyl fumarate - azamun is used as an immunosuppressant anti-metabolite either alone, or more commonly in combination with other agents (usually corticosteroids) and procedures that influence the immune response. the therapeutic effect of azamun may be evident only after weeks or months and can include a steroid-sparing effect, thereby reducing the toxicity associated with high dosage and prolonged use of corticosteroids. azamun, in combination with corticosteroids and/or other immune-suppressive agents and procedures is indicated to enhance survival of organ transplants, such as renal, cardiac and hepatic transplants; and to reduce corticosteroid requirements of renal transplant recipients.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - azathioprine 75mg;   - film coated tablet - 75 mg - active: azathioprine 75mg   excipient: croscarmellose sodium maize starch mannitol microcrystalline cellulose opadry clear oy-7240 povidone sodium stearyl fumarate - azamun is used as an immunosuppressant anti-metabolite either alone, or more commonly in combination with other agents (usually corticosteroids) and procedures that influence the immune response. the therapeutic effect of azamun may be evident only after weeks or months and can include a steroid-sparing effect, thereby reducing the toxicity associated with high dosage and prolonged use of corticosteroids. azamun, in combination with corticosteroids and/or other immune-suppressive agents and procedures is indicated to enhance survival of organ transplants, such as renal, cardiac and hepatic transplants; and to reduce corticosteroid requirements of renal transplant recipients.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - amlodipine mesilate 12.79mg equivalent to amlodipine 10 mg;  ;   - tablet - 10 mg - active: amlodipine mesilate 12.79mg equivalent to amlodipine 10 mg     excipient: calcium hydrogen phosphate magnesium stearate microcrystalline cellulose sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - amlodipine mesilate 6.395mg equivalent to amlodipine 5.0 mg;  ;   - tablet - 5 mg - active: amlodipine mesilate 6.395mg equivalent to amlodipine 5.0 mg     excipient: calcium hydrogen phosphate magnesium stearate microcrystalline cellulose sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - bisoprolol fumarate 10mg;   - tablet - 10 mg - active: bisoprolol fumarate 10mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose sodium starch glycolate - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - bisoprolol fumarate 2.5mg;   - tablet - 2.5 mg - active: bisoprolol fumarate 2.5mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose sodium starch glycolate - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - bisoprolol fumarate 5mg;   - tablet - 5 mg - active: bisoprolol fumarate 5mg   excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose sodium starch glycolate - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.